Drugs / PF-00217830
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00580125 | Nov 2007 → Sep 2008 | schizophrenia | Pfizer | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-00217830 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00580125 ↗ |
| Known as | J2.975.999E | ChEMBL registry synonym — accepted as the source's own label CHEMBL1774080 ↗ |
| Known as | PF-217830 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1774080 ↗ |
| Action | Activate | “Dopamine D2 receptor partial agonist” CHEMBL1774080 ↗ |
| Modality | Small molecule | — CHEMBL1774080 ↗ |
| Route | Oral | “oral capsule” NCT00580125 ↗ |
| Target | DRD2 | “Dopamine D2 receptor partial agonist” CHEMBL1774080 ↗ |